Download PDF
Synfacts 2020; 16(04): 0470
DOI: 10.1055/s-0040-1707564
Chemistry in Medicine and Biology
© Georg Thieme Verlag Stuttgart · New York

Modular, Targeted IDO Inhibitor for Cancer Immunotherapy

Authors

    Contributor(s):

  • Dirk Trauner

  • Alexander J. E. Novak

Further Information

Publication History

Publication Date:
18 March 2020 (online)

   Permissions and Reprints
Preview

Key words

cancer immunotherapy - prodrugs - IDO inhibitors - PD-L1